MISAA/TacAssay

MISAA/TacAssayMISAA/TacAssayMISAA/TacAssay
  • Home
  • About MISAA
  • Value Proposition
  • Who are we
  • Scientific Advisory Board
  • Industry Feedback
  • News
  • More
    • Home
    • About MISAA
    • Value Proposition
    • Who are we
    • Scientific Advisory Board
    • Industry Feedback
    • News

MISAA/TacAssay

MISAA/TacAssayMISAA/TacAssayMISAA/TacAssay
  • Home
  • About MISAA
  • Value Proposition
  • Who are we
  • Scientific Advisory Board
  • Industry Feedback
  • News

industry feedback

Andrew Klein, M.D - Cedars Sinai

“Reducing time between blood draw to test will allow for dose adjustment in matter of hours as opposed to days. Lead to better patient outcome.”


Irene Kim, M.D. - Cedars Sinai

“Home tests are a better market as the doctor’s office is equipped with a battery of tests all of which are needed for the doctor to diagnosis”


Vijay Gorantla, M.D., MMM, PhD. - Wake Forest

“The sensitivity of the assay is comparable to the best in the business.”


Kamyar Kalantar, M.D., MPH, PhD. - UC Irvine

“Very excited to partner with IOS for the Tacrolimus assay. They see compelling value in Tacrolimus and Cystatin C assays.”

Copyright © 2024 MISAA/TacAssay - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept